Weekly docetaxel in ormone refractory prostate cancer patients

被引：0
|
作者：
Lupo, G. [1 ]
Buemi, B. [1 ]
Marabello, G. [1 ]
Pettineo, G. [1 ]
Gnani, A. [1 ]
Caristi, N. [1 ]
Leone, A. [1 ]
Altavilla, G. [1 ]
机构：
[1] Univ Messina, Med Oncol & Innovat Therapies, I-98100 Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII153 / VII153
页数：1
相关论文
共 50 条
  • [21] Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer
    Coccaro, M
    Tartarone, A
    Romano, G
    Ardito, R
    Di Renzo, N
    TUMORI, 2005, 91 (04) : 314 - 316
  • [22] A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC).
    Oh, WK
    Hagmann, E
    Manola, J
    George, DJ
    Gilligan, TD
    Smith, MR
    Kaufman, DS
    Kantoff, PW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 420S - 420S
  • [23] Phase II trial of weekly docetaxel, zoledronic acid and selenium for hormone refractory prostate cancer
    Kattan, J. G.
    Ghosn, M.
    Chahine, G.
    Saroufim, A.
    Nasr, F.
    Farhat, F. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Weekly Docetaxel and Pegylated liposomal doxorubicin (PLD) in metastatic hormone refractory prostate cancer (HRPC)
    Pacilio, G.
    De Filippis, L.
    Simeon, D.
    De Domenico, R.
    ANNALS OF ONCOLOGY, 2005, 16 : 154 - 154
  • [25] Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer
    Yasufuku, Tomihiko
    Shigemura, Katsumi
    Matsumoto, Osamu
    Arakawa, Soichi
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (03) : 200 - 205
  • [26] A phase II study of weekly docetaxel (T), estramustine (E), and celecoxib (C) in patients with hormone refractory prostate cancer (HRPC).
    Mellado, B
    Font, A
    Carles, J
    Catalán, G
    Larriba, JLG
    Gallardo, E
    Fernández, LA
    Nogué, M
    Lianes, P
    Del Alba, AG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 434S - 434S
  • [27] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Villa, Eugenio
    Cereda, Stefano
    Mazza, Elena
    Vigano, Maria Grazia
    Vitali, Giordano
    Rognone, Alessia
    Di Carlo, Valerio
    Reni, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 15 - 15
  • [28] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Cereda, S.
    Reni, M.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (04) : 509 - 512
  • [29] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Cereda, S.
    Mazza, E.
    Vigano, M.
    Passoni, P.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V.
    Reni, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII113 - VII113
  • [30] Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
    Hainsworth, JD
    Burris, HA
    Erland, JB
    Thomas, M
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2164 - 2168
12345